pharma · Acute Pain
Menarini
Menarini Group
Menarini Group is a pharma organization headquartered in CN. Primary therapeutic focus areas include Acute Pain. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from p
Firenze, IT HQ
12,911 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Firenze, IT
- Employees
- 12,911
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Placebo
Phase 3 · small molecule · Acute Pain
Placebo for Acute Pain is a Phase 3 program (small_molecule) at Menarini Group with 1 ClinicalTrials.gov record(s).
Internal code DEX-TRA-05
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Menarini Group
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Acute Pain
- Status
- completed
- Trials
- 1